dc.contributor.author | Ergur, AT | |
dc.contributor.author | Tanzer, F | |
dc.contributor.author | Cetinkaya, O | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T10:25:50Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T10:25:50Z | |
dc.date.issued | 1999 | |
dc.identifier.issn | 0142-6338 | |
dc.identifier.uri | https://dx.doi.org/10.1093/tropej/45.3.168 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/11751 | |
dc.description | WOS: 000081136900011 | en_US |
dc.description | PubMed ID: 10401197 | en_US |
dc.description.abstract | The serum-free carnitine (SFC) levels of 91 children with heart failure (HF) and of a control group consisting of 30 healthy children were measured, Twenty-four of 91 children with HF were administered oral L-carnitine. The mean SFC level of children with NF (20.16+/-0.30nmol/l) was significantly lower than that of the control group (38.98 +/- 0.79 nmol/ml) (p < 0.01), Mean SPC levels of 24 patients, after L-carnitine administration, increased significantly (p < 0.01). Patients administered L-carnitine displayed a marked difference in time taken for clinical improvement compared with those not given oral L-carnitine, | en_US |
dc.language.iso | eng | en_US |
dc.publisher | OXFORD UNIV PRESS | en_US |
dc.relation.isversionof | 10.1093/tropej/45.3.168 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Serum-free carnitine levels in children with heart failure | en_US |
dc.type | article | en_US |
dc.relation.journal | JOURNAL OF TROPICAL PEDIATRICS | en_US |
dc.contributor.department | Cumhuriyet Univ, Fac Med, Dept Pediat, Sivas, Turkey -- Cumhuriyet Univ, Fac Med, Dept Biochem, Sivas, Turkey | en_US |
dc.identifier.volume | 45 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.endpage | 169 | en_US |
dc.identifier.startpage | 168 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |